Vincent Bouldoires

General Manager at Novelion Therapeutics - , ,

Vincent Bouldoires's Contact Details
HQ
N/A
Location
Company
Novelion Therapeutics
Vincent Bouldoires's Company Details
Novelion Therapeutics logo, Novelion Therapeutics contact details

Novelion Therapeutics

, , • 250 - 499 Employees
Other

Novelion Therapeutics is a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases. Novelion has a diversified commercial portfolio through its indirect subsidiary, Aegerion Pharmaceuticals, Inc. (Aegerion), which includes MYALEPT® and JUXTAPID®, and is also developing zuretinol acetate for the potential treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes. The company seeks to advance its portfolio of rare disease therapies by investing in science and clinical development.

N/A
Details about Novelion Therapeutics
Frequently Asked Questions about Vincent Bouldoires
Vincent Bouldoires currently works for Aegerion Pharmaceuticals.
Vincent Bouldoires's role at Aegerion Pharmaceuticals is General Manager.
Vincent Bouldoires's email address is ***@novelion.com. To view Vincent Bouldoires's full email address, please signup to ConnectPlex.
Vincent Bouldoires works in the Biotechnology industry.
Vincent Bouldoires's colleagues at Novelion Therapeutics are Rosa Barrett, Rachel Sorensen, Nic Scalfarotto, Michael Graham, Peter Ksenuk, Kristin Kallio, Lisa Collias and others.
Vincent Bouldoires's phone number is N/A
See more information about Vincent Bouldoires